EUVIMEDEUVIMED entdecken
EditorialKommentar

Promising results for treatment of severe chronic hand eczema with dupilumab

Richard Brans iD

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljad199 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Richard Brans. Beteiligte Einrichtung: Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at Osnabrück University. Hauptthemen laut MEDLINE: Eczema. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EczemaHumansAlitretinoinDouble-Blind MethodAntibodies, Monoclonal, Humanized

Substanzen

dupilumabAlitretinoinAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at Osnabrück University.
  • Department of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Germany.

ORCID-Profile: Richard Brans

Zitieren

APA

Brans, R. (2023). Promising results for treatment of severe chronic hand eczema with dupilumab. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad199

Vancouver

Brans R. Promising results for treatment of severe chronic hand eczema with dupilumab. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad199

BibTeX
@article{Brans2023,
  author = {Brans, Richard},
  title = {Promising results for treatment of severe chronic hand eczema with dupilumab},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljad199}
}
Kostenlos starten →